[CAS NO. ]  Gap19 TFA

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS

Catalog
HY-P1136A
Brand
MCE
CAS
-

DESCRIPTION

Overview

MDL-
Molecular Weight1275.46
Molecular FormulaC57H97F3N14O15
SMILES-

For research use only. We do not sell to patients.

1 Publications Citing Use of MCE


Summary

Gap19 TFA, a peptide derived from nine amino acids of the Cx43 cytoplasmic loop (CL), is a potent and selective connexin 43 (Cx43) hemichannel blocker. Gap19 TFA inhibits hemichannels caused by preventing intramolecular interactions of the C-terminus (CT) with the CL. Gap19 TFA is not blocking GJ channels or Cx40/pannexin-1 hemichannels. Gap19 TFA has protective effects against myocardial [1] [2] .


IC50 & Target

Cx43 Hemichannel [1]


In Vitro

Gap19 TFA (250 μM; for 30 min ) decreases mitochondrial potassium uptake [1] .
Gap19 TFA (400 μM) inhibits unitary hemichannel currents in HeLa-Cx43 cells [2] .
Gap19 TFA (100 μM) inhibits hemichannel unitary currents in ventricular cardiomyocytes [2] .
Gap19 TFA (250 μM, 30 min) protects against myocardial ischemia/reperfusion injury in vitro and in vivo [2] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


In Vivo

Gap19 TFA (iv; 25 mg/kg; 10 min before ligation) significantly reduces the infarct size by approximately one-fifth [2] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: C57/BL6 mice [2]
Dosage: 25 mg/kg
Administration: IV; 10 min before ligation
Result: Significantly reduced the infarct size by approximately one-fifth.

Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Sealed storage, away from moisture

Powder -80°C 2 years
-20°C 1 year

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)


Solvent & Solubility

In Vitro:

DMSO : 100 mg/mL ( 78.40 mM ; Need ultrasonic)

H 2 O : 100 mg/mL ( 78.40 mM ; Need ultrasonic)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 0.7840 mL 3.9202 mL 7.8403 mL
5 mM 0.1568 mL 0.7840 mL 1.5681 mL
10 mM 0.0784 mL 0.3920 mL 0.7840 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: PBS

    Solubility: 100 mg/mL (78.40 mM); Clear solution; Need ultrasonic

* All of the co-solvents are available by MCE.